Abstract
Biological protein-based entities that form nanostructures ranging from 8 to 50 nm in size represent promising candidates in the development of novel immunotherapeutics against cancer and microbial pathogens. These recombinant nanoparticles usually consist of major coat or core proteins derived from viruses like for instance papillomavirus, polyomavirus, parvovirus or hepatitis B virus that spontaneously assemble into these highly ordered, supramolecular, icosahedral structures. By genetic engineering of permissive sites or cross-linking to surface-exposed subunit domains these nanoparticles successfully serve as carrier matrix with per se adjuvant activity for the delivery of appropriate guest peptides, protein fragments and complete proteins. Using this nanobiotechnology, potent humoral and cell-mediated immunity with emphasis on CD4 and CD8 T cell responses are induced against self or non-self foreign antigens representing appropriate immunostimulatory epitopes or complete proteins of microbial pathogens or tumor-associated antigens. Breaking of T and B cell tolerance required for therapeutic interventions against cancer represents the hallmark of such an outstanding antigen delivery system. In combination with the increasing identification of validated target antigens from pathogens or tumors, and promising progress in bioprocess development, such nanostructures offer novel homologous or heterologous treatment and prevention opportunities against a variety of malignant and infectious diseases.
Keywords: Virus-like-particles, Antigen delivery, Vaccines, Infectious diseases, Cancer and Nanobiotechnology
Current Nanoscience
Title: Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention
Volume: 2 Issue: 4
Author(s): Christoph Reichel, Marc Brinkman, Claus Ruehland, Christian O. A. Reiser and Juergen Hess
Affiliation:
Keywords: Virus-like-particles, Antigen delivery, Vaccines, Infectious diseases, Cancer and Nanobiotechnology
Abstract: Biological protein-based entities that form nanostructures ranging from 8 to 50 nm in size represent promising candidates in the development of novel immunotherapeutics against cancer and microbial pathogens. These recombinant nanoparticles usually consist of major coat or core proteins derived from viruses like for instance papillomavirus, polyomavirus, parvovirus or hepatitis B virus that spontaneously assemble into these highly ordered, supramolecular, icosahedral structures. By genetic engineering of permissive sites or cross-linking to surface-exposed subunit domains these nanoparticles successfully serve as carrier matrix with per se adjuvant activity for the delivery of appropriate guest peptides, protein fragments and complete proteins. Using this nanobiotechnology, potent humoral and cell-mediated immunity with emphasis on CD4 and CD8 T cell responses are induced against self or non-self foreign antigens representing appropriate immunostimulatory epitopes or complete proteins of microbial pathogens or tumor-associated antigens. Breaking of T and B cell tolerance required for therapeutic interventions against cancer represents the hallmark of such an outstanding antigen delivery system. In combination with the increasing identification of validated target antigens from pathogens or tumors, and promising progress in bioprocess development, such nanostructures offer novel homologous or heterologous treatment and prevention opportunities against a variety of malignant and infectious diseases.
Export Options
About this article
Cite this article as:
Reichel Christoph, Brinkman Marc, Ruehland Claus, A. Reiser O. Christian and Hess Juergen, Heterologous Virus-Like-Particles: Recombinant Nanosystems as Versatile Antigen Delivery Devices for Immune Intervention, Current Nanoscience 2006; 2 (4) . https://dx.doi.org/10.2174/157341306778699338
DOI https://dx.doi.org/10.2174/157341306778699338 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Therapeutic Effects of Curcumin
Current Pharmaceutical Design Antiangiogenic Therapy
Current Pharmaceutical Design Quinone-Based Drugs: An Important Class of Molecules in Medicinal Chemistry
Medicinal Chemistry Lipid based Nanocapsules: A Multitude of Biomedical Applications
Current Pharmaceutical Biotechnology PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
Current Cancer Drug Targets Tumor-Induced Alterations in Lipid Metabolism
Current Medicinal Chemistry Overexpression of Nemo-like Kinase Promotes the Proliferation and Invasion of Lung Cancer Cells and Indicates Poor Prognosis
Current Cancer Drug Targets Targeting the G2/M Transition for Antitumor Therapy
Letters in Drug Design & Discovery Allergy and Inflammation: An Immunological and Therapeutic Approach
Recent Patents on Inflammation & Allergy Drug Discovery Therapeutic Applications of Liposomal Based Drug Delivery and Drug Targeting for Immune Linked Inflammatory Maladies: A Contemporary View Point
Current Drug Targets Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
Current Cancer Drug Targets Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy
Current Cancer Therapy Reviews A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer
Current Cancer Drug Targets Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition
Current Pharmaceutical Design Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy
Current Medicinal Chemistry Carbonic Anhydrase Based Biomarkers: Potential Application in Human Health and Environmental Sciences
Current Biomarkers (Discontinued) Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Current Drug Targets Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Current Topics in Medicinal Chemistry The Yin and Yang of Non-Neuronal α7-Nicotinic Receptors in Inflammation and Autoimmunity
Current Drug Targets Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry